Literature DB >> 6622885

Cardiobacterium hominis: review of microbiologic and clinical features.

G P Wormser, E J Bottone.   

Abstract

Cardiobacterium hominis, like other fastidious, opportunistic gram-negative bacilli, including Actinobacillus actinomycetemcomitans, Haemophilus aphrophilus, and Eikenella corrodens, is increasingly recognized as a cause of human disease. In this review the microbiologic and clinical features of C. hominis are discussed. The findings are based on observations of two infected patients (the case history of one was reported previously) and on reports in the literature of 32 others. Microbiologically, the chief distinguishing features of C. hominis are its characteristic colonial morphotype and its production of indole. Infection with C. hominis is clinically distinctive because of its chronic course (averaging 169 days among patients with endocarditis), the absence of documented infection outside of the bloodstream, and the high degree of responsiveness to treatment with penicillin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6622885     DOI: 10.1093/clinids/5.4.680

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  20 in total

1.  Infective endocarditis in a child caused by Cardiobacterium hominis after right ventricular outflow tract reconstruction using an expanded tetrafluoroethylene conduit.

Authors:  Yoshiyuki Maekawa; Takahiko Sakamoto; Kentaroh Umezu; Noburoh Ohashi; Yorikazu Harada
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-06-15

2.  Fastidious gram-negative, facultatively anaerobic rods: a renewed interest.

Authors:  A von Graevenitz
Journal:  Eur J Clin Microbiol       Date:  1984-06       Impact factor: 3.267

3.  Phenotypic differentiation of Cardiobacterium hominis, Kingella indologenes and CDC group EF-4.

Authors:  B Bruun; Y Ying; E Kirkegaard; W Frederiksen
Journal:  Eur J Clin Microbiol       Date:  1984-06       Impact factor: 3.267

4.  Infective endocarditis complicated with progressive heart failure due to beta-lactamase-producing Cardiobacterium hominis.

Authors:  P L Lu; P R Hsueh; C C Hung; L J Teng; T N Jang; K T Luh
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

Review 5.  Cardiobacterium hominis endocarditis: Two cases and a review of the literature.

Authors:  A N Malani; D M Aronoff; S F Bradley; C A Kauffman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-09       Impact factor: 3.267

6.  Direct detection of Cardiobacterium hominis in serum from a patient with infective endocarditis by broad-range bacterial PCR.

Authors:  N Gatselis; E Malli; G Papadamou; E Petinaki; G N Dalekos
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

7.  Endocarditis caused by Cardiobacterium valvarum.

Authors:  Elisabeth Bothelo; Frédérique Gouriet; Pierre-Edouard Fournier; Véronique Roux; Gilbert Habib; Franck Thuny; Dominique Metras; Didier Raoult; Jean-Paul Casalta
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

8.  Cardiobacterium hominis endocarditis in a patient with a hypersensitivity reaction to penicillin. Successful treatment with partial resection of the posterior mitral valve leaflet and antibiotic therapy with cefazolin.

Authors:  R D Christen
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

9.  Endocarditis with ruptured cerebral aneurysm caused by Cardiobacterium valvarum sp. nov.

Authors:  Xiang Y Han; Michelle C Meltzer; Joan T Woods; Victor Fainstein
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

10.  Cardiobacterium hominis endocarditis: A case report and review of the literature.

Authors:  Andrew Walkty
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-09       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.